Stay ahead of the curve and gain valuable knowledge that can help bring a market access mindset to your commercial and development strategies.
In our last post, we spoke about the critical importance of Payer engagement. A question we often hear from clients on that topic is, “When should that process start?”...
With an ever-increasing number of complex, game changing medicines coming to market, there has never been a more important time for effective engagement with both private and public payers...
During our tenure as biopharma executives, and now as advisors, we have observed, first-hand, very common missteps organizations make when building and executing their market access strategies...
With an ever-increasing number of complex, game changing medicines coming to market, there has never been a more important time for effective engagement with both private and public payers. The pace of innovation is...
We believe there is still an opportunity for first-in-class and best in class medicines to achieve premium pricing and commercial success. But… the margin for error is getting slimmer and slimmer...